Related references
Note: Only part of the references are listed.Novel GPR40 agonist AS2575959 exhibits glucose metabolism improvement and synergistic effect with sitagliptin on insulin and incretin secretion
Hirotsugu Tanaka et al.
LIFE SCIENCES (2014)
Chronic glucolipotoxic conditions in pancreatic islets impair insulin secretion due to dysregulated calcium dynamics, glucose responsiveness and mitochondrial activity
Baggavalli P. Somesh et al.
BMC CELL BIOLOGY (2013)
TAK-875, a GPR40/FFAR1 agonist, in combination with metformin prevents progression of diabetes and β-cell dysfunction in Zucker diabetic fatty rats
R. Ito et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Randomized, Double-Blind, Dose-Ranging Study of TAK-875, a Novel GPR40 Agonist, in Japanese Patients With Inadequately Controlled Type 2 Diabetes
Kohei Kaku et al.
DIABETES CARE (2013)
Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats
Nagesh Gowda et al.
BMC PHARMACOLOGY & TOXICOLOGY (2013)
GLP-1 based therapies: differential effects on fasting and postprandial glucose
M. S. Fineman et al.
DIABETES OBESITY & METABOLISM (2012)
TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial
Charles F. Burant et al.
LANCET (2012)
The Effects of TAK-875, a Selective G Protein-Coupled Receptor 40/Free Fatty Acid 1 Agonist, on Insulin and Glucagon Secretion in Isolated Rat and Human Islets
Hiroaki Yashiro et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
AMG 837: A Novel GPR40/FFA1 Agonist that Enhances Insulin Secretion and Lowers Glucose Levels in Rodents
Daniel C. -H. Lin et al.
PLOS ONE (2011)
Evidence that low-grade systemic inflammation can induce islet dysfunction as measured by impaired calcium handling
Stacey B. Dula et al.
CELL CALCIUM (2010)
G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: The role of type 2 diabetes and fatty acids
S. Del Guerra et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2010)
Deletion of GPR40 Impairs Glucose-Induced Insulin Secretion In Vivo in Mice Without Affecting Intracellular Fuel Metabolism in Islets
Thierry Alquier et al.
DIABETES (2009)
Overexpression of GPR40 in Pancreatic β-Cells Augments Glucose-Stimulated Insulin Secretion and Improves Glucose Tolerance in Normal and Diabetic Mice
Kae Nagasumi et al.
DIABETES (2009)
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
Ralph A. DeFronzo
DIABETES (2009)
The incretin system and its role in type 2 diabetes mellitus
Jens Juul Holst et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Glucose modulates [Ca2+]i oscillations in pancreatic islets via ionic and glycolytic mechanisms
Craig S. Nunemaker et al.
BIOPHYSICAL JOURNAL (2006)
Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules
Celia P. Briscoe et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Genome-wide analysis of restriction-modification system in unicellular and filamentous cyanobacteria
FQ Zhao et al.
PHYSIOLOGICAL GENOMICS (2006)
Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients
CG Ostenson et al.
DIABETES (2006)
Oleic acid interacts with GPR40 to induce Ca2+ signaling in rat islet β-cells:: mediation by PLC and L-type Ca2+ channel and link to insulin release
K Fujiwara et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Role of GPR40 in fatty acid action on the β cell line INS-1E
H Shapiro et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Loss of ARNT/HIF1β mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes
JE Gunton et al.
CELL (2005)
Functional and molecular defects of pancreatic islets in human type 2 diabetes
S Del Guerra et al.
DIABETES (2005)
Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients
M Anello et al.
DIABETOLOGIA (2005)
Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects
SP Deng et al.
DIABETES (2004)
Subcellular distribution of the inositol 1,4,5-trisphosphate receptors: functional relevance and molecular determinants
E Vermassen et al.
BIOLOGY OF THE CELL (2004)
First-phase insulin secretion: does it exist in real life? Considerations on shape and function
A Caumo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids
CP Briscoe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
Y Itoh et al.
NATURE (2003)
beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes
AE Butler et al.
DIABETES (2003)
Glucose-stimulated signaling pathways in biphasic insulin secretion
SG Straub et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2002)
Is reduced first-phase : Insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes?
JE Gerich
DIABETES (2002)
Decreased insulin secretion in type 2 diabetes: A problem of cellular mass or function?
A Clark et al.
DIABETES (2001)
Differential patterns of glucose-induced electrical activity and intracellular calcium responses in single mouse and rat pancreatic islets
CM Antunes et al.
DIABETES (2000)
Transgenic reexpression of GLUT1 or GLUT2 in pancreatic β cells rescues GLUT2-null mice from early death and restores normal glucose-stimulated insulin secretion
B Thorens et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Differential regulation of [Ca2+](i) oscillations in mouse pancreatic islets by glucose, alpha-ketoisocaproic acid, glyceraldehyde and glycolytic intermediates
S Lenzen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2000)